Liposomal Gel Dosage Form

Liposomal gel systems constitute a structurally robust, aqueous- or hydro-alcoholic-based semi-solid matrix designed to immobilize phospholipid vesicles while providing a cooling, non-greasy cutaneous delivery vehicle. The polymeric network is engineered to provide controlled structural relaxation upon application, ensuring optimal release kinetics for encapsulated actives. Matrix architecture is tuned to balance gelling agent concentration with vesicular stability, preventing premature rupture of the lipid bilayers.

Key Technical Development Parameters

• Polymeric network architecture: Selection of compatible hydrophilic gelling agents to ensure optimal cross-linking density, clarity, and structural integrity.
• Viscoelastic profiling: Measurement of storage modulus, loss modulus, and flow recovery to guarantee optimal squeeze-tube dispensing and skin adherence.
• Controlled release kinetics: Evaluation of diffusion coefficients and swelling indices to validate sustained local bioavailability of the entrapped active ingredients.
• Superior encapsulation and payload protection: Advanced vesicular integration that shields unstable active ingredients from environmental degradation and premature oxidation, far outperforming conventional unformulated hydrogels.
• Enhanced dermal penetration efficiency: Liposome-facilitated transdermal transport that overcomes the rigid barrier limitations of standard polymer gels, delivering superior local bioavailability and deeper tissue saturation.